POMC and neoplasm: Although there were no significant differences in body weights and plasma ACTH levels between the control group and the HX630 treated group (data not shown), HX630 significantly decreased the tumor volumes (Fig 7A–7E) as well as Pomc mRNA expressions in the tumor cells (Fig 7F).